ctrl K

Monte Rosa Therapeutics I... (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

4.96

0.06 (1.22%)

At close: May 02, 2025, 3:59 PM

4.97

0.30%

After-hours: May 02, 2025, 04:05 PM EDT

Monte Rosa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	224.25M	128.1M	54.91M	346.07M	41.7M	6M
Short-Term Investments	147.9M	104.31M	207.91M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	4.32M	5.34M	1.16M	n/a
Other Long-Term Assets	4.98M	4.93M	278K	n/a	n/a	n/a
Receivables	173K	505K	7.66M	n/a	n/a	n/a
Inventory	n/a	n/a	960K	n/a	n/a	n/a
Other Current Assets	5.12M	3.29M	5.4M	2.6M	n/a	3.3M
Total Current Assets	377.44M	236.21M	275.89M	348.67M	43.59M	9.76M
Property-Plant & Equipment	56.31M	62.61M	61.91M	12.32M	4.62M	1.33M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	61.29M	67.54M	66.5M	17.66M	5.79M	1.33M
Total Assets	438.73M	303.75M	342.39M	366.33M	49.38M	11.09M
Account Payables	17.21M	11.15M	7.86M	6.56M	7.07M	3.19M
Deferred Revenue	117.23M	17.68M	n/a	n/a	n/a	n/a
Short-Term Debt	3.71M	n/a	3.13M	n/a	n/a	750K
Other Current Liabilities	11.57M	9.26M	7.52M	840K	21.08M	n/a
Total Current Liabilities	156.95M	46.59M	25.57M	16.64M	29.27M	4.29M
Long-Term Debt	n/a	n/a	n/a	n/a	67.76M	n/a
Other Long-Term Liabilities	42.7M	2.71M	1.53M	2.18M	n/a	n/a
Total Long-Term Liabilities	58.85M	77.91M	45.41M	2.18M	68.83M	18.95M
Total Liabilities	215.8M	124.5M	70.98M	18.81M	98.11M	23.24M
Total Debt	42.72M	46.04M	47M	n/a	67.76M	750K
Common Stock	6K	5K	5K	5K	1K	50K
Retained Earnings	-438.59M	-365.89M	-230.54M	-122.03M	-48.08M	-12.2M
Comprehensive Income	-3.36M	-2.72M	-1.75M	-2.02M	-1.06M	-68.95K
Shareholders Equity	222.94M	179.25M	271.41M	347.51M	-48.73M	-12.15M
Total Investments	147.9M	104.31M	207.91M	5.34M	1.16M	n/a